healthcare medical

news/blog

corporate

English

_ga_Z6X95SN0X9

The domain name 'www.center4research.org' uses the non-profit oriented generic top-level domain (.org); it also runs on subdomain 'www'. The second-level label 'center4research' is 15 characters long with 5 vowels and nine consonants, plus one digit. Segmentation suggests 3 words: center, 4, research. Average segment length settles at six characters. No strong language cues emerged from the frequency lists.

html/e4/15/e415cd6a-893a-4b94-b393-1a9dea837438.html.gz

require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha-scs

script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:106:0

AddToAny Utility Frame

d4883381009ff8e5c4b05722f62b60f6182b1d2a0631d12fe4075026bac1929f

cec72174cceb8d24af1a378c6b9ab1fa9326c116d543cc32c277b716bf98163e

96d83d578e572cd76c1ca89f8645181e54f8ad990fdab87138219fbdb28a63b0

7790882b18f7b3e10750f4474dc1a13150a2ef8510ef4c2e3e52c5d5f776db87

53d16f311b01e5f9b5e7dcb2ec11b11e5ed23e155ed05727a7a42472d608118f

cb6f2d32c49d1c2b25e9ffc9aaafa3f83075346c01bcd4ae6eb187392a4292cf

5274f11e6fb32ae0cf2dfb9f8043272865c397a7c4223b4cfa7d50ea52fbde89

50679e0e3933c945348a2db0cc128bb14b57a60a74fabf8cae13acc14efbb2e1

292d24e79b1e264ced629c35d3b59a7a83093f972cdd0eac61e7b32189964772

db8ee8be2b2456c191fc0739f34f6ac675af8ba4782380cf233024498e0eb968

92e58830c2fd351b1c590e9825bcc0d758f464bf5e213997bac3b7407c7ff39c

77a54ffede097e512d30298191303926804bf721363eda6f00aba63a77b1376f

01682e2634057072539342a0a934e040152f1d4bc9a52de15e18beec7d2afba1

d6c8da4dc0b049d0845a02577c4e184639db5969570e09f9bc220f8986102365

“limited benefits” and “significant harms”

an advocacy group supported by Pfizer, Bayer

studying combined estrogen and progesterone

A7vZI3v+Gz7JfuRolKNM4Aff6zaGuT7X0mf3wtoZTnKv6497cVMnhy03KDqX7kBz/q/iidW7srW31oQbBt4VhgoAAACUeyJvcmlnaW4iOiJodHRwczovL3d3dy5nb29nbGUuY29tOjQ0MyIsImZlYXR1cmUiOiJEaXNhYmxlVGhpcmRQYXJ0eVN0b3JhZ2VQYXJ0aXRpb25pbmczIiwiZXhwaXJ5IjoxNzU3OTgwODAwLCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==

viewport

New York Times July 17, 2025: This FDA panel hosted by Commissioner Makary ignores evidence of the serious risks of hormone therapy for menopause, such as breast cancer, endometrial cancer, and stroke. Instead it focuses only on benefits, relying on misleading and erroneous information. The panel wants to remove the "black box" warning that tells women about the risks. No public comment was allowed at the meeting. We would have disagreed strongly, except with the issue of whether hormonal cream used in the vagina should not have the same black box warning as the hormonal pills.

description

robots

author

generator

National Center for Health Research - The Voice For Prevention, Treatment and Policy

F.D.A. Panel to Reassess Hormone Therapy Warnings - National Center for Health Research

https://www.center4research.org/f-d-a-panel-to-reassess-hormone-therapy-warnings/

twitter:card

twitter:title

twitter:description

NYT previews FDA panel hosted by Commissioner Makary that ignores evidence of risks of hormone therapy for menopause and focuses only on benefits

F.D.A. Panel to Reassess Hormone Therapy Warnings

http://www.facebook.com/nationalresearchcenter

twitter:creator

twitter:site

twitter:label1

twitter:data1

twitter:label2

twitter:data2

https://www.center4research.org/wp-content/uploads/2017/01/nchr-icon-300x300.png

msapplication-TileImage

HSTS header missing - vulnerable to protocol downgrade attacks

CSP header missing - vulnerable to XSS attacks

child-src 'none';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources 'self';trusted-types;worker-src blob: 'self';frame-ancestors 'none';

child-src https:  chrome-untrusted://new-tab-page/ chrome-untrusted://ntp-microsoft-auth/;connect-src chrome://resources chrome://theme 'self';default-src 'self';font-src chrome://resources 'self';img-src chrome://resources chrome://theme chrome://image chrome://favicon2 chrome://app-icon chrome://extension-icon chrome://fileicon blob: data: 'self';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources chrome://webui-test 'self';style-src chrome://resources chrome://theme 'self' 'unsafe-inline';trusted-types parse-html-subset sanitize-inner-html static-types webui-test-script webui-test-html polymer-html-literal polymer-template-event-attribute-policy lit-html-desktop;frame-ancestors 'none';

child-src 'none';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources 'self';trusted-types;frame-ancestors 'none';

base-uri 'none';child-src https:;form-action https://ogs.google.com https://*.corp.google.com;object-src 'none';script-src 'self' 'unsafe-inline' https:;frame-ancestors chrome://new-tab-page/


			{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.center4research.org\/f-d-a-panel-to-reassess-hormone-therapy-warnings\/#blogposting","name":"F.D.A. Panel t

{"@context":"https://schema.org","@graph":[{"@type":"WebPage","@id":"https://www.center4research.org/f-d-a-panel-to-reassess-hormone-therapy-warnings/","url":"https://www.center4research.org/f-d-a-pan


				var mi_version = '9.9.0';
				var mi_track_user = true;
				var mi_no_track_reason = '';
								var MonsterInsightsDefaultLocations = {"page_location":"https:\/\/www.center4research.org\/f-d-a-p


/* <![CDATA[ */
window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/16.0.1\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/16.0.1\/svg\/","svgExt":"

/* <![CDATA[ */
var monsterinsights_frontend = {"js_events_tracking":"true","download_extensions":"doc,pdf,ppt,zip,xls,docx,pptx,xlsx","inbound_paths":"[]","home_url":"https:\/\/www.center4research.or


/* <![CDATA[ */
window.a2a_config=window.a2a_config||{};a2a_config.callbacks=[];a2a_config.overlays=[];a2a_config.templates={};
/* ]]> */


//<![CDATA[
  function external_links_in_new_windows_loop() {
    if (!document.links) {
      document.links = document.getElementsByTagName('a');
    }
    var change_link = false;
    var force = '


{"prefetch":[{"source":"document","where":{"and":[{"href_matches":"\/*"},{"not":{"href_matches":["\/wp-*.php","\/wp-admin\/*","\/wp-content\/uploads\/*","\/wp-content\/*","\/wp-content\/plugins\/*","


			var localizedErrMap = {};
			localizedErrMap['required'] =    'This field is required.';
			localizedErrMap['ca'] =      'An unexpected error occurred while attempting to send email.';
			localize

Google authentication and security services

Google

✅ Low Risk - https://www.center4research.org/f-d-a-panel-to-reassess-hormone-therapy-warnings/

Requests	IP Address	Location	AS Autonomous System
6	142.250.186.35	Unknown	Unknown
2	52.119.45.110	Unknown	Unknown
2	104.20.20.192	Unknown	Unknown
2	216.58.206.68	Unknown	Unknown
2	216.239.32.36	Unknown	Unknown
2	142.250.181.232	Unknown	Unknown
2	172.66.171.172	Unknown	Unknown
2	172.64.147.103	Unknown	Unknown
2	2606:4700:10::ac42:abac	Unknown	Unknown
2	2a00:1450:4001:81c::2008	Unknown	Unknown
42	19	-	-

Security Scan Report: www.center4research.org

Summary

AI Security Verdict

Safe Website

Safety Factors

Details

Screenshot

Page Load Overview

Language Analysis

Primary Language

Detection Details

Website Classification

Primary Category

All Detected Categories

Detected Features

Domain & IP Information

Content Similarity HashesFor malware variant detection

TLSH (Trend Micro Locality Sensitive Hash)

ssdeep (Context Triggered Piecewise Hashing)

sdhash (Similarity Digest Hashing)

Image Hashes

Perceptual Hashes

Other Hashes

Scan History